Publicacions en què col·labora amb E. Espinosa Arranz (10)

2024

  1. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

    Clinical and Translational Oncology

2021

  1. Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 6, pp. 586-598

2017

  1. Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

    Medicine, Vol. 96, Núm. 52, pp. e9523

2016

  1. Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1147-1157

2014

  1. Guidelines for biomarker testing in metastatic melanoma: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 362-373

  2. Recomendaciones para la determinación de biomarcadores en el melanoma metastásico. Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica

    Revista Espanola de Patologia

2013

  1. Treatment of metastatic melanoma

    Cancer and Chemotherapy Reviews, Vol. 8, Núm. 2, pp. 84-89

2012

  1. Advances in cutaneous melanoma

    Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 325-332

2009

  1. Immunotherapy of distant metastatic disease

    Annals of Oncology, Vol. 20, Núm. SUPPL. 4

  2. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

    European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735